Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children
Allergy · 2026
DOI: 10.1111/all.70111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, 2026. Verfasst von Neel Singh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulin E, Peanut Hypersensitivity, Sublingual Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Food Allergy Research and Education, NCCIH NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The safety and efficacy of 36‐month peanut sublingual immunotherapy (SLIT) was recently demonstrated in peanut‐allergic children (1–4 years old), with high remission rates three months post‐treatment.
Methods
We performed a post hoc analysis of longitudinal changes in peanut component‐specific IgE (PnC‐sIgE) and IgG4 (PnC‐sIgG4) levels in 1–4 year olds who underwent peanut SLIT to uncover immune mechanisms and potential biomarkers of remission. Plasma from 30 participants was analyzed at 0, 12, 24, 36, and 39 months using ImmunoCAP250 for PnC‐sIgE and PnC‐sIgG4 to Ara h 1, Ara h 2, Ara h 3, and Ara h 6 (Ah1‐6). Mixed‐effects models assessed longitudinal antibody changes, Wilcoxon tests compared antibody levels by remission status, and correlations evaluated age and baseline antibody levels.
Results
Peanut SLIT reduced IgE levels while increasing IgG4 levels specific to Pn and Ah1‐6 over 36 months. No changes in sIgE were observed in the placebo group, whereas increases in Pn‐, Ah1‐, and Ah3‐sIgG4 were noted. Participants achieving remission had lower IgE and IgG4 to Pn and Ah1‐6 at baseline and throughout 36 months of SLIT. Ah2‐sIgG4 showed no overlap between outcome groups at baseline, suggesting potential as a biomarker. Children under 3 had lower baseline Ah6‐sIgE and Ah1‐, Ah2‐, and Ah6‐sIgG4 levels and higher remission rates than those 3 and older, linking age, remission, and antibody profiles.
Conclusion
Component‐resolved analysis offers key insights into the immunological mechanisms in young children undergoing peanut SLIT, revealing lower baseline levels of Ah2‐sIgG4 as a potential biomarker of remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Department of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, USA.
- Curriculum in Toxicology and Environmental Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Neel Singh, Janelle Kesselring, Jess Humphrey, Lauren Herlihy, A Wesley Burks, Johanna Smeekens, Corinne Keet, J Andrew Bird, Edwin H Kim, Michael Kulis
Förderung
- NIH HHS
- Food Allergy Research and Education
- NCCIH NIH HHS
- University of North Carolina at Chapel Hill
- Meade Family Pediatric Allergy Research Fund
- NCATS NIH HHS
- National Institutes of Health
- National Center for Complementary and Integrative Health
Zitieren
APA
Singh, N., Kesselring, J., Humphrey, J., Herlihy, L., Burks, A. W., Smeekens, J., Keet, C., Bird, J. A., Kim, E. H., & Kulis, M. (2026). Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children. Allergy. https://doi.org/10.1111/all.70111
Vancouver
Singh N, Kesselring J, Humphrey J, Herlihy L, Burks AW, Smeekens J, et al. Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children. Allergy. 2026. doi:10.1111/all.70111
BibTeX
@article{Singh2026,
author = {Singh, Neel and Kesselring, Janelle and Humphrey, Jess and Herlihy, Lauren and Burks, A Wesley and Smeekens, Johanna and Keet, Corinne and Bird, J Andrew and Kim, Edwin H and Kulis, Michael},
title = {Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children},
journal = {Allergy},
year = {2026},
doi = {10.1111/all.70111}
}
EUVIMED